13F HOLDINGS REPORT
NEA Management Company, LLC
Quarter ended Q4 2025 · Filed February 17, 2026 · Accession 0001072613-26-000191
Total Value
$1.96B
Positions
27
Other Managers
0
Confidential Omitted
No
Holdings (27)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Celcuity Inc. | CELC | 3,535,561 | $352.6M | 17.98% |
| 2 | Rhythm Pharmaceuticals, Inc. | RYTM | 2,909,956 | $311.5M | 15.88% |
| 3 | Arcellx, Inc. | ACLX | 3,045,262 | $198.6M | 10.12% |
| 4 | Trevi Therapeutics, Inc. | TRVI | 13,222,228 | $165.5M | 8.44% |
| 5 | Savara, Inc. | SVRA | 24,471,264 | $147.6M | 7.52% |
| 6 | Zenas BioPharma, Inc. | ZBIO | 3,523,219 | $127.9M | 6.52% |
| 7 | Monte Rosa Therapeutics, Inc. | GLUE | 7,692,298 | $120.6M | 6.15% |
| 8 | MBX Biosciences, Inc. | MBX | 3,614,486 | $114.0M | 5.81% |
| 9 | Coursera, Inc. | COUR | 12,867,769 | $94.7M | 4.83% |
| 10 | Aurinia Pharmaceuticals, Inc. | AUPH | 3,969,834 | $63.3M | 3.23% |
| 11 | Gossamer Bio, Inc. | GOSS | 18,093,034 | $56.1M | 2.86% |
| 12 | CRISPR Therapeutics AG | CRSP | 1,058,570 | $55.5M | 2.83% |
| 13 | ORIC Pharmaceuticals, Inc. | ORIC | 4,118,621 | $33.7M | 1.72% |
| 14 | Phathom Pharmaceauticals, Inc. | PHAT | 1,960,169 | $32.5M | 1.66% |
| 15 | CVRx, Inc. | CVRX | 2,026,083 | $14.4M | 0.73% |
| 16 | X4 Pharmaceuticals, Inc. | XFOR | 3,233,743 | $12.9M | 0.66% |
| 17 | Champions Oncology, Inc. | CSBR | 1,713,720 | $11.8M | 0.60% |
| 18 | Black Diamond Therapeutics, Inc. | BDTX | 4,448,757 | $10.8M | 0.55% |
| 19 | Korro Bio, Inc. | KRRO | 1,090,793 | $8.7M | 0.45% |
| 20 | Inventiva SA | IVEVF | 1,462,586 | $6.8M | 0.35% |
| 21 | Nkarta, Inc. | NKTX | 3,568,781 | $6.6M | 0.34% |
| 22 | Senti Biosciences, Inc. | SNTI | 3,775,615 | $3.9M | 0.20% |
| 23 | LeonaBio, Inc. | 04746L203 | 464,398 | $3.5M | 0.18% |
| 24 | Synlogic, Inc. | SYBX | 2,922,772 | $3.3M | 0.17% |
| 25 | Marker Therapeutics, Inc. | MRKR | 1,625,678 | $2.4M | 0.12% |
| 26 | OnKure Therapeutics, Inc. | OKUR | 478,548 | $1.4M | 0.07% |
| 27 | ImageneBio, Inc. | IMA | 50,005 | $345,035 | 0.02% |